Retrospective comparison of the patency of Wallstents and Palmaz long-medium stents used for TIPS

CardioVascular and Interventional Radiology

Volumn 23, Issue 5, 2000, Pages 332-339

  Borsa, John J ^a   Fontaine, Arthur B ^a   Hoffer, Eric K ^a   Bloch, Robert D ^a   Tong, Eugene ^a   Kuhr, Christian S ^a   Kowdley, Kris V ^a   Schmiedl, Udo P ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Stents; Transjugular intrahepatic portosystemic shunt

Indexed keywords

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENDOPROSTHESIS; FEMALE; FOLLOW UP; HUMAN; MALE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROSTHESIS FAILURE; STENT; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; ASCITES; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STENTS; SURVIVAL ANALYSIS; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR PATENCY;

EID: 0033709313     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002700010082     Document Type: Article

References (42)

1. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding
2. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement
3. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: Results in 90 patients
4. Transjugular intrahepatic portosystemic shunt with the strecker stent for control of refractory acute and chronic variceal bleeding
5. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding
6. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage
7. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage: A randomized, controlled trial
8. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage
9. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding
10. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): State of the art
11. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices
12. Refractory ascites: Midterm results of treatment with a transjugular intrahepatic portosystemic shunt
13. Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of refractory ascites
14. Transjugular intrahepatic portosystemic shunts for refractory ascites: Assessment of clinical and hormonal response and renal function
15. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites
16. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt
17. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites
18. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax
19. Hepatic hydrothorax
20. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax
21. Transjugular intrahepatic portosystemic shunt: Angiographic follow-up and secondary interventions
22. Is the role of transjugular intrahepatic portosystemic shunts limited in the management of patients with end-stage liver disease?
23. Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms
24. Patency and reintervention rates during routine TIPSS surveillance
25. Stenosis of transjugular intrahepatic portosystemic shunts: Presentation and management
26. Creation of transjugular intrahepatic portosystemic shunts with the Wallstent endoprosthesis: Results in 100 patients
27. Transjugular intrahepatic portosystemic shunts using the Wallstent prosthesis: A follow-up study
28. Transjugular intrahepatic portosystemic shunting (TIPS) with balloon-expandable and self-expanding stents: Technical and clinical aspects after 3 1/2 years' experience
29. Primary placement of Palmaz long-medium stents in transjugular intrahepatic portosystemic shunts
30. 2 fine-needle TIPS
31. Use of carbon dioxide as a contrast medium for transjugular intrahepatic portosystemic shunt procedures
32. Use of CT-guided marking of the portal vein in creation of 150 transjugular intrahepatic portosystemic shunts
33. Comparison of mechanical deformation properties of metallic stems with use of stress-strain analysis
34. Transjugular intrahepatic portosystemic shunt (TIPS): Thrombogenicity in stents and its effect on shunt patency
35. Platelet-derived growth factor
36. Downstream anastomotic hyperplasia: A mechanism of failure in Dacron arterial grafts
37. Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: A randomized study comparing trapidil plus ticlopidine with heparin treatment
38. Liver transplantation complicated by malpositioned transjugular intrahepatic portosystemic shunts
39. Transjugular intrahepatic portosystemic shunts: Impact on liver transplantation
40. Liver transplantation complicated by misplaced TIPS in the portal vein
41. Reporting standards for transjugular intrahepatic portosystemic shunts. Technology Assessment Committee of the SCVIR
42. Transjugular intrahepatic portosystemic shunt procedure: Efficacy of 10-mm versus 12-mm Wallstents